๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
The purpose of this study is to evalute the response and toxicity of metast...
Status
Completed
Location
The West Clinic
Start Date
2006-02
Trial ID
NCT00786643
Treatments Being Tested
This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2015-11-02
Trial ID
NCT02429843
Treatments Being Tested
The aim of this work is to assess the antitumor effect of Pentoxiphylline i...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06115174
Treatments Being Tested
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
A single institution, single arm, two-cohort feasibility trial to evaluate ...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2026-03-26
Trial ID
NCT07059494
Treatments Being Tested
This is a Phase 1/Phase 2 study assessing liothyronine (L-T3) immunotherapy...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2026-08-21
Trial ID
NCT07346157
Treatments Being Tested
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805